http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7517312-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fb55cdab8e0f79867802d464faa71e8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2205-084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2205-086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2205-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2201-1642
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2201-163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2205-108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2205-106
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H99-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H23-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-362
filingDate 2004-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_404602f07e45f9b6d503637759f6797d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a9cd2e0ab6e2062412c85a097d47948
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86c700fb16e6047c2c8014b220d5e234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6adec2e98a135ae5a2ae695da1fc7a3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_328e736f69f5031a0eb0e0f00e48a499
publicationDate 2009-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7517312-B2
titleOfInvention External counter pulsation treatment
abstract A method for treating patients suffering from left ventricular dysfunction, exhibited by a left ventricular ejection fraction (LVEF) less than normal, is disclosed. The method involves applying, during diastole, for a time period of about one hour, about five days each week for at least about seven weeks, an incrementally increasing therapeutic pressure to the patients' lower extremities, from the calves through the thighs and the buttocks. The hourly treatments are carried out at incrementally increasing peak diastolic/systolic pressure ratios (D/S Ratios) in the range of about 0.4:1 up to about 0.6:1 and thereafter at a D/S Ratio in the range of 0.5:1 to 1:1 for each consecutive hourly treatment, with the proviso that the average D/S Ratio over the entire treatment regimen does not exceed about 0.9:1.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10195103-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8128550-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10252052-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9119759-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9119761-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11602540-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE47219-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10136895-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010292619-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010305607-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009247809-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11045207-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011190807-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9393025-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10426835-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10098779-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9205019-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11642274-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10213206-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10987273-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10272241-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10194918-B2
priorityDate 2003-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003216651-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4510

Total number of triples: 54.